A comparison of carboplatin and paclitaxel with cisplatinum and 5-fluorouracil in definitive chemoradiation in esophageal cancer patients-Reference-Cited by-同舟云学术

A comparison of carboplatin and paclitaxel with cisplatinum and 5-fluorouracil in definitive chemoradiation in esophageal cancer patients

Published:2014-03 Issue:3 Volume:25 Page:638-643
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Honing J.,Smit J.K.,Muijs C.T.,Burgerhof J.G.M.,de Groot J.W.,Paardekooper G.,Muller K.,Woutersen D.,Legdeur M.J.C.,Fiets W.E.,Slot A.,Beukema J.C.,Plukker J.Th.M.,Hospers G.A.P.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/25/3/638/16699375/mdt589.pdf

Reference16 articles.

1. Oesophageal cancer in The Netherlands: increasing incidence and mortality but improving survival;Crane;Eur J Cancer,2007

2. Dutch Cancer Registration2005Survival of esophageal cancer patients in the Netherlands www.cijfersoverkanker.nl/selecties/Dataset_2/img512d09a0bce07 8 September 2013, data last accessed

3. Continuing rapid increase in esophageal adenocarcinoma in England and Wales;Lepage;Am J Gastroenterol,2008

4. Oesophageal carcinoma;Pennathur;Lancet,2013

5. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis;Sjoquist;Lancet Oncol,2011

Cited by 106 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reduction in chemotherapy relative dose intensity decreases overall survival of neoadjuvant chemoradiotherapy in patients with locally advanced esophageal carcinoma;BMC Cancer;2024-08-02

2. Efficient synthesis and molecular docking analysis of quinazoline and azole hybrid derivatives as promising agents for anti-cancer and anti-tuberculosis activities;Journal of Molecular Structure;2024-08

3. Capecitabine or Capecitabine Plus Oxaliplatin Versus Fluorouracil Plus Cisplatin in Definitive Concurrent Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma (CRTCOESC): A Multicenter, Randomized, Open-Label, Phase 3 Trial;Journal of Clinical Oncology;2024-07-10

4. Reduction in Chemotherapy Relative Dose Intensity Decreases Overall Survival of Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Esophageal Carcinoma;2024-03-11

5. Avances presentes y futuros en el tratamiento del cáncer esofagogástrico;Medicina;2023-12-31